Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-02-20 pm EST 5-day change 1st Jan Change
377.6 USD -0.24% Intraday chart for Intuitive Surgical, Inc. -0.33% +11.94%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Intuitive Surgical Insider Sold Shares Worth $31,418,468, According to a Recent SEC Filing MT
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking... Our Logo
Which Jerome will we get? Our Logo
ANALYST RECOMMENDATIONS : GM, Verizon, Fortinet, Microsoft, AMD... Our Logo
Intuitive Surgical Insider Sold Shares Worth $11,004,743, According to a Recent SEC Filing MT
Intuitive Surgical Insider Sold Shares Worth $1,598,298, According to a Recent SEC Filing MT
Intuitive Surgical Insider Sold Shares Worth $2,478,032, According to a Recent SEC Filing MT
Intuitive Surgical Insider Sold Shares Worth $740,405, According to a Recent SEC Filing MT
Raymond James Raises Price Target on Intuitive Surgical to $435 From $372, Keeps Outperform Rating MT
Citigroup Raises Price Target on Intuitive Surgical to $428 From $390, Keeps Buy Rating MT
Evercore ISI Adjusts Price Target on Intuitive Surgical to $385 From $335, Keeps In Line Rating MT
Baird Raises Price Target on Intuitive Surgical to $440 From $380, Keeps Outperform Rating MT
Mizuho Adjusts Price Target on Intuitive Surgical to $390 From $350, Keeps Neutral Rating MT
Global markets live: EasyJet, Netflix, AT&T, eBay, Apple... Our Logo
Stifel Adjusts Price Target on Intuitive Surgical to $420 From $360, Maintains Buy Rating MT
Deutsche Bank Adjusts Intuitive Surgical Price Target to $370 From $275, Maintains Hold Rating MT
Truist Securities Increases Price Target on Intuitive Surgical to $435 From $390, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on Intuitive Surgical to $375 From $330, Maintains Equal-Weight Rating MT
Barclays Hikes Price Target on Intuitive Surgical to $430 From $385, Maintains Overweight Rating MT
BTIG Raises Price Target on Intuitive Surgical to $412 From $392, Maintains Buy Rating MT
JPMorgan Raises Price Target on Intuitive Surgical to $475 From $325, Maintains Overweight Rating MT
Piper Sandler Raises Intuitive Surgical Price Target to $425 From $325, Maintains Overweight Rating MT
Upcoming Big-Cap Tech Earnings Boost Exchange-Traded Funds, Equity Futures Pre-Bell Wednesday MT
RBC Raises Price Target on Intuitive Surgical to $432 From $400, Sees 'Substantial Upside Potential' Ahead, Keeps Outperform Rating MT
Stock Futures Rise Premarket Ahead of More Corporate Earnings; Asia, Europe Up MT
Chart Intuitive Surgical, Inc.
More charts
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (56.5%): primarily wrist cuffs; - sale of robotic systems (27%): systems marketed under the da Vinci brand (1,264 units sold in 2022) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.5%). The United States accounts for 66.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
377.6 USD
Average target price
408.5 USD
Spread / Average Target
+8.16%
Consensus
  1. Stock
  2. Equities
  3. Stock Intuitive Surgical, Inc. - Nasdaq
  4. News Intuitive Surgical, Inc.
  5. Deutsche Bank Adjusts Intuitive Surgical Price Target to $275 From $335, Maintains Hold Rating
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer